02.2023
We are delighted to see our portfolio company, RORA Biologics complete its exclusive license agreement with Case Western Reserve University (Cleveland, Ohio, USA) for cancer and HIV therapy technologies developed by its Chief Scientific Officer Dr. Rafick Sékaly. RORA-Bio is using this technology to develop potential treatments for certain cancers and people living with HIV.